August 25, 2015
Hiroshi Yamazaki, Business Development Director, EvaluatePharma Japan Global sales of five immune checkpoint inhibitors are forecast to reach 2 trillion yen in 2020, according to EvaluatePharma, a London-based market research firm specializing in the pharmaceutical industry. In the eighth of...read more